Josep Domingo-Domenech

[Fulminant hepatic failure as form of presentation of a peripheral T cell lymphoma].

Low thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur.

Differential cellular and molecular effects of bortezomib, a proteasome inhibitor, in human breast cancer cells.

Whole brain irradiation and temozolomide based chemotherapy in melanoma brain metastases.

Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.

Clinical outcome after surgical resection of lung metastases from melanoma.

Toxicity of combined treatment of adjuvant irradiation and interferon alpha2b in high-risk melanoma patients.

Prognostic implications of protein S-100beta serum levels in the clinical outcome of high-risk melanoma patients.

Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma.

Molecular pathways of urothelial development and bladder tumorigenesis.

Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.

Predictive value of microtubule associated proteins tau and stathmin in patients with nonmuscle invasive bladder cancer receiving adjuvant intravesical taxane therapy.

Anatomical features of the urethra and urinary bladder catheterization in female mice and rats. An essential translational tool.

PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.

A BAC-based transgenic mouse specifically expresses an inducible Cre in the urothelium.

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.

Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches.

A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancer.

Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.

Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.

Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why?

The role of GATA2 in lethal prostate cancer aggressiveness.

Targeting sarcoma tumor-initiating cells through differentiation therapy.